Hide metadata

dc.date.accessioned2022-01-25T18:45:30Z
dc.date.available2022-01-25T18:45:30Z
dc.date.created2021-12-31T11:07:27Z
dc.date.issued2021
dc.identifier.citationTsuruda, Kaitlyn Veierød, Marit Bragelien Houssami, Nehmat Wåde, Gunvor Gipling Mangerud, Gunhild Hofvind, Solveig . Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study. BMJ Open. 2021, 11(12), 1-10
dc.identifier.urihttp://hdl.handle.net/10852/90079
dc.description.abstractObjective To investigate conceptual knowledge about mammographic screening among Norwegian women. Design We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. Setting Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45–74 years. Participants 2033 women completed our questionnaire. We excluded 13 women outside the target age range and 128 women with incomplete data. Responses from 1892 women were included in the final study sample. Primary and secondary outcome measures The questionnaire focused on women’s knowledge about the breast cancer mortality reduction, false positive results and overdiagnosis associated with mammographic screening. The primary outcome was the mean number of marks assigned in each of the three themes and overall. There were three potential marks for questions about breast cancer mortality, one for false positives and six for overdiagnosis. Results Most women (91.7%) correctly reported that screened women are less likely to die of breast cancer than non-screened women. 39.7% of women reported having heard of a ‘false positive screening result’ and 86.2% identified the term’s definition; 51.3% of women had heard of ‘overdiagnosis’ and 14.8% identified the term’s definition. The mean score was 2.59 of 3 for questions about breast cancer mortality benefit and 0.93 of 1 for the question about false positive screening results. It was 2.23 of 6 for questions about overdiagnosis. Conclusions Most participants correctly answered questions about the breast cancer mortality benefit and false positive results associated with screening. The proportion of correct responses to questions about overdiagnosis was modest, indicating that conceptual knowledge about overdiagnosis was lower. Qualitative studies that can obtain in-depth information about women’s understanding of overdiagnosis may help improve Norwegian-language information about this challenging topic.
dc.languageEN
dc.publisherBMJ Publishing Group
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleWomen’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
dc.typeJournal article
dc.creator.authorTsuruda, Kaitlyn
dc.creator.authorVeierød, Marit Bragelien
dc.creator.authorHoussami, Nehmat
dc.creator.authorWåde, Gunvor Gipling
dc.creator.authorMangerud, Gunhild
dc.creator.authorHofvind, Solveig
cristin.unitcode185,51,15,0
cristin.unitnameAvdeling for biostatistikk
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1973126
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ Open&rft.volume=11&rft.spage=1&rft.date=2021
dc.identifier.jtitleBMJ Open
dc.identifier.volume11
dc.identifier.issue12
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2021-052121
dc.identifier.urnURN:NBN:no-92738
dc.subject.nviVDP::Epidemiologi medisinsk og odontologisk statistikk: 803VDP::Forebyggende medisin: 804
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2044-6055
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/90079/1/e052121.full.pdf
dc.type.versionPublishedVersion
cristin.articleide052121
dc.relation.projectEXTRA/2018/FO201362


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International